The potential benefit of angiotensin II-receptor antagonism is not limited ... the angiotensin type 1 receptor and a lack of agonist activity at this receptor site. All the agents are orally ...

Objective: We evaluated the renoprotective effects as reflected by short-term changes in albuminuria of dual blockade of the renin-angiotensin system (RAS) by adding an angiotensin II receptor ...

the maximum dose approved by the Food and Drug Administration and the dose used in the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study. 3 Patients who ...

Renin–angiotensin system (RAS) inhibitors — including angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) — slow the progression of mild or moderate ...

DALLAS—Halving the dosage of furosemide in patients with stable class II ... GFR group but not in the group with normal renal function. Results showed no change in activation of the renin ...